Skip to content

Clinical study on inhibiting inflammation injury of granulomatous mastitis caused by stagnating heat of liver meridian with Chaihu Qinggan Decoction

Clinical study on inhibiting inflammation injury of granulomatous mastitis caused by stagnating heat of liver meridian with Chaihu Qinggan Decoction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081632
Enrollment
Unknown
Registered
2024-03-07
Start date
2024-03-20
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

granulomatous mastitis

Interventions

treatment group :The patients were treated with traditional Chinese medicine decoction after enrollment. Traditional Chinese medicine decoction is decocted by Pharmacy of Shuguang Hospital, one patch
control group:patients were given prednisolone acetate tablets (5mg/ tablet) after enrollment. The initial oral dose was 10mg twice daily, decreasing by one tablet per week to a maintenance dose of 5m

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Women aged 20-50 who are married and have children; (2) Meet the diagnostic criteria for disease and TCM syndrome; (3) Meet the diagnostic criteria of acute stage of clinical disease course; (4) Patients voluntarily participate and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Pregnant and lactating women; (2) Patients with diseases of serious cardiovascular and cerebrovascular system, respiratory system, digestive system, blood system, urinary system, nervous system, endocrine system and serious trauma. (3) Patients with other autoimmune diseases such as systemic lupus erythematosus, Sjogren's syndrome, autoimmune thyroid disease, type I diabetes, etc.; (4) subacute and chronic patients with granulomatous mastitis.

Design outcomes

Primary

MeasureTime frame
Granulomatous Mastitis’ Disease Activity Index;

Secondary

MeasureTime frame
Time to recovery or clinical cure;Recurrence rate and recurrence time;breast elasticity ultrasound;Blood routine examination;C-reactive protein;Erythrocyte sedimentation rate ;prolactin;Cytokines;

Countries

China

Contacts

Public ContactXie Lu

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

xlsummer1994@163.com+86 131 6299 3573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026